Impact of Adherence to Guideline‐Directed Prevention Strategies on Clinical Outcomes in Patients With Coronary Artery Disease and Diabetes Mellitus Following Acute Coronary Syndrome: A 3‐Year Cohort Study
Clinical Cardiology · 2025
DOI: 10.1002/clc.70164 ↗Kurz gefasst
Leitlinie in der Zeitschrift Clinical Cardiology, 2025. Verfasst von Nur Kamer Kaya İnalkaç und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, İstanbul University-Cerrahpasa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Coronary Artery Disease, Guideline Adherence, Secondary Prevention. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Coronary artery disease (CAD) and diabetes mellitus (DM) significantly increase the risk after acute coronary syndrome. This study evaluated adherence to guideline‐directed secondary prevention strategies and demonstrated their substantial impact on reducing rehospitalization and mortality in this population.
Methods
A retrospective cohort study was conducted on 987 CAD and DM patients admitted for ACS between 2015 and 2018. Adherence to seven evidence‐based secondary prevention strategies was assessed: smoking cessation, physical activity, antiplatelet therapy, statins, blood pressure control, ACEi/ARB therapy, and SGLT‐2i therapy. Patients were categorized into groups based on the number of recommendations followed (0–2, 3–4, and 5+). Primary outcomes included rehospitalization and all‐cause mortality over a 3‐year follow‐up period.
Results
At baseline, only 12.4% of patients adhered to five or more recommendations, which dramatically increased to 71.9% by the 3‐year follow‐up. Individual adherence to each of blood pressure control (HR = 0.81, 95% CI: 0.70–0.94), ACEi/ARB therapy (HR = 0.77, 95% CI: 0.67–0.89), and SGLT‐2i therapy (HR = 0.79, 95% CI: 0.68–0.92) significantly reduced rehospitalization risk. Similarly, adherence to these therapies individually reduced mortality risk (HR = 0.78, 95% CI: 0.67–0.91; HR = 0.74, 95% CI: 0.63–0.87; and HR = 0.72, 95% CI: 0.61–0.85, respectively). Importantly, a stepwise increase in adherence was associated with a dose‐dependent reduction in mortality (HR = 0.65, 95% CI: 0.52–0.81, p < 0.05).
Conclusion
This study highlights the critical role of comprehensive, multifactorial secondary prevention in its association with improved long‐term outcomes in patients with CAD and DM following ACS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, İstanbul University-Cerrahpasa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye.
- Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Educatıon Research Hospıtal, İstanbul, Türkiye.
- University of Health Sciences, İstanbul, Türkiye.
ORCID-Profile: Nur Kamer Kaya İnalkaç, Fuat Polat, İbrahim Keleş
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
İnalkaç, N. K. K., Polat, F., & Keleş, İ. (2025). Impact of Adherence to Guideline‐Directed Prevention Strategies on Clinical Outcomes in Patients With Coronary Artery Disease and Diabetes Mellitus Following Acute Coronary Syndrome: A 3‐Year Cohort Study. Clinical Cardiology. https://doi.org/10.1002/clc.70164
Vancouver
İnalkaç NKK, Polat F, Keleş İ. Impact of Adherence to Guideline‐Directed Prevention Strategies on Clinical Outcomes in Patients With Coronary Artery Disease and Diabetes Mellitus Following Acute Coronary Syndrome: A 3‐Year Cohort Study. Clinical Cardiology. 2025. doi:10.1002/clc.70164
BibTeX
@article{nalka2025,
author = {İnalkaç, Nur Kamer Kaya and Polat, Fuat and Keleş, İbrahim},
title = {Impact of Adherence to Guideline‐Directed Prevention Strategies on Clinical Outcomes in Patients With Coronary Artery Disease and Diabetes Mellitus Following Acute Coronary Syndrome: A 3‐Year Cohort Study},
journal = {Clinical Cardiology},
year = {2025},
doi = {10.1002/clc.70164}
}
EUVIMED